The global micro syringes market size was estimated at USD 219.1 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.2% from 2023 to 2030. The market is expanding as a result of the rise in both the volume and number of life science research projects. Preclinical research, clinical trials, and drug observations are expected to boost the market growth as pharmaceutical and biomedical businesses strengthen their efforts to manufacture effective medicines. Due to the medical device sector's intensive research efforts to generate novel treatments, there is an increasing need for micro syringes. In addition, commercial expansion is encouraged by government financing for primary and basic research.
The existence of significant players in this sector is anticipated to produce profitable market expansion. Agilent Technologies Inc. has partnered with Akoya Biosciences in January 2023 to promote the development of Multiplex Tissue Assays for Biopharma applications. The new assays will speed up the progression of research findings to clinical testing and assist scientists and healthcare providers in fulfilling patient selection criteria for novel treatments in the U.S. Agilent intends to set aside USD 22 million for the growth of its Newport facility. COVID-19 has further underscored the significance of accurate and efficient liquid handling in vaccine development and testing, driving up the demand for micro syringes.
The hospitals segment accounted for the largest revenue share of around 47.0% in 2022. Different types of micro syringes are frequently needed in hospitals to accommodate various medical specializations, including diagnostics, anesthesia, and oncology. The segment's growth is being driven by factors such as improvements in patient care, ongoing medical technology development, and advances in healthcare practices.
The outpatient facilities segment is estimated to register the fastest CAGR of 6.5% over the forecast period. The growing tendency toward ambulatory services and outpatient care is in line with the flexibility and convenience of outpatient facilities. The micro syringes industry under this segment is anticipated to have continuous expansion driven by technology improvements and a focus on patient-centric healthcare solutions, as outpatient clinics continue to expand and diversify their medical offerings. For instance, the essential guidelines for prevention and control of infections by the CDC for safe healthcare provision in all environments.
North America dominated the market with the largest revenue share of over 40% in 2022 and is expected to maintain its dominance during the forecast period. Major factors contributing to the growth of this region include the growing incidence of chronic illnesses, improvements in healthcare technologies, and heavy investments in R&D. For instance, Agilent plans to allocate $22 million for the expansion of its Newport plant. The COVID-19 pandemic has also highlighted how important, precise, and effective liquid handling is for vaccine development and testing, which has increased the demand for micro syringes even more.
Asia Pacific is expected to grow at the fastest CAGR of 7.6% during the forecast period. Automation and digital advancements are being incorporated into micro syringes by laboratories and healthcare facilities to improve operational efficiency in the region. Cooperative efforts and regional standardization of legislation may significantly influence the regulatory landscape for medical devices in the larger Asia Pacific region.
The autosampler syringes segment accounted for the largest revenue share of around 63.0% in 2022 and is estimated to register the fastest CAGR of 6.4% over the forecast period. Autosampler syringes are precise instruments used by researchers in lab settings to automatically inject liquid samples into instruments like liquid or gas chromatographs. These syringes are a crucial component of automated systems because they allow for high-throughput sample analysis with a reduced requirement for human involvement.
These syringes increase the efficiency and dependability of analytical processes and are particularly helpful in environments like forensic, pharmaceutical, and environmental laboratories where precision and consistency are essential. For instance, PerkinElmer, Inc. uses these autosampler syringes for routine analysis. Every clarus GC instrument comes with a conventional needle with a metal plunger in the barrel that is sealed with a PTFE tip.
The micro syringes industry is highly competitive, with a large number of manufacturers accounting for most of the market share. Syringes launches, approvals, strategic acquisitions, partnerships, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.
Report Attribute |
Details |
Market size value in 2023 |
USD 230.9 million |
Revenue forecast in 2030 |
USD 352.8 million |
Growth rate |
CAGR of 6.2% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Report updated |
November 2023 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Syringe type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait |
Key companies profiled |
Innovative Labor Systeme (ILS); GL Science, Inc.; Hamilton Company; PerkinElmer, Inc.; Agilent Technologies Inc.; Shimadzu Corporation; Avantor; Valco Instruments Company Inc.; Zoetis Services; Trajan Scientific and Medical |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global micro syringes market report based on syringe type, end-use and region:
Syringe Type Outlook (Revenue, USD Million, 2018 - 2030)
Autosampler Syringes
Manual Syringes
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Research & Manufacturing
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. North America dominated the micro syringes market with a share of 37.8% in 2022. This is attributable to the huge investments in R&D, technological advancements in the analytical techniques leading to proper detection of proteins; metabolites; other complex molecules.
b. Some key players operating in the micro syringes market include are Innovative Labor Systeme (ILS), GL Science, Inc.; Hamilton Company; PerkinElmer, Inc.; Shimadzu Corporation; Trajan Scientific and Medical; Avantor; ITO Corporation; Valco Instruments Company Inc.; and Agilent Technologies Inc.
b. Key factors that are driving the market growth include an increasing number of research studies, increasing demand for pharmaceutical products, and the rising volume of life science research investigations.
b. The global micro syringes market size was estimated at USD 219.1 million in 2022 and is expected to reach USD 230.9 million in 2023.
b. The global micro syringes market is expected to grow at a compound annual growth rate of 6.2% from 2023 to 2030 to reach USD 352.8 million by 2030.
"The quality of research they have done for us has been excellent."